The Care of Children and Adolescents with Chronic Inflammatory Bowel Disease

被引:0
|
作者
Tischler, Luisa [1 ,2 ]
Boerkoel, Aletta [1 ,2 ]
Krause, Heiko [1 ,2 ]
van den Berg, Neeltje [1 ,2 ]
de Laffolie, Jan [3 ]
机构
[1] Greifswald Univ Hosp, Inst Community Med, Rostock Site, Greifswald, Germany
[2] German Ctr Pediat & Adolescent Med DZKJ, Rostock Site, Gottingen, Germany
[3] Justus Liebig Univ Giessen, Ctr Pediat & Adolescent Med, Dept Gen Pediat & Neonatol, Giessen, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2024年 / 121卷 / 19期
关键词
CROHNS-DISEASE; DIAGNOSIS; GUIDELINE;
D O I
10.3238/arztebl.m2024.0168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: For children and adolescents with chronic inflammatory bowel disease (IBD), treatment that is not in adequate conformity with the guidelines can adversely affect both the course of disease and the patients' development. The targeted use of digital patient registries may improve real-life adherence to the recommendations of evidence-based guidelines. Methods: In a cluster-randomized, controlled trial (DRKS00015505), treatment providers for the intervention group (IG) documented the treatment of children and adolescents with IBD in the CEDATA-GPGE patient registry; they received automated feedback on the data they entered and on potential deviations of the documented treatment from recommendations contained in the guidelines (care deficits). Treatments providers for the control group (CG) documented treatments as previously, i.e., only in the patients' charts. At the end of a twelve-month observation period, the data from both groups at baseline and on follow-up were analyzed in an intergroup comparison. The primary endpoint was the number of care deficits at twelve months. Results: 319 patients were recruited from 47 pediatric gastroenterological centers in Germany (IG: 21 centers and 160 subjects; CG: 26 centers and 159 subjects). Among the 146 subjects in the IG who were followed up at 12 months, there were an average (mean) of 0.17 care deficits per patient (95% confidence interval [0.10; 0.24]). Among the 134 subjects in the CG who were followed up at 12 months, there were an average (mean) of 0.55 [0.43; 0.66] identified care deficits per patient (p < 0.0001). Conclusion: Registry-based feedback can help bring treatment and its documentation into better con for- mity with the relevant guidelines and thereby reduce or prevent care deficits in children and adolescents with IBD.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Infliximab use in children and adolescents with inflammatory bowel disease
    de Ridder, Lissy
    Benninga, Marc A.
    Taminiau, Jan A. J. M.
    Hommes, Daan W.
    van Deventer, Sander J. H.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 45 (01): : 3 - 14
  • [32] MANAGEMENT OF CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL-DISEASE
    MICHENER, WM
    WYLLIE, R
    MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (01) : 103 - 117
  • [33] Erythropoietin levels in children and adolescents with inflammatory bowel disease
    Tsitsika, A
    Stamoulakatou, A
    Kafritsa, Y
    Paleologos, G
    Panayotou, I
    Premetis, E
    Roma, E
    Papassotiriou, I
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (02) : 93 - 96
  • [34] Skeletal Health of Children and Adolescents With Inflammatory Bowel Disease
    Pappa, Helen
    Thayu, Meena
    Sylvester, Francisco
    Leonard, Mary
    Zemel, Babette
    Gordon, Catherine
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 53 (01): : 11 - 25
  • [35] Changing epidemiology of inflammatory bowel disease in children and adolescents
    Long, Dan
    Wang, Chenchen
    Huang, Yingtao
    Mao, Chenhan
    Xu, Yin
    Zhu, Ying
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
  • [36] Infliximab therapy in children and adolescents with inflammatory bowel disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    DRUGS, 2007, 67 (12) : 1703 - 1723
  • [37] Radiological diagnostics of chronic inflammatory bowel diseases in children and adolescents
    Nagy, E.
    Sorantin, E.
    MONATSSCHRIFT KINDERHEILKUNDE, 2020, 168 (04) : 323 - 331
  • [38] Bone markers in chronic inflammatory bowel diseases in children and adolescents
    Kusec, V.
    Cala, I. Senecic
    Dujsin, M.
    Vukovic, J.
    Hojsak, I.
    Kolacek, S.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S87 - S87
  • [39] Chronic inflammatory bowel disease in childhood and adolescence.: Initial symptoms, diagnosis, treatment -: Data recorded in the Register of Chronic Inflammatory Bowel Disease in Children and Adolescents in Saxony
    Meier, C.
    Thoennessen, C.
    Rothe, U.
    Henker, J.
    Quietzsch, J.
    Prager, J.
    Buerk, G.
    Kiess, W.
    Richter, T.
    MONATSSCHRIFT KINDERHEILKUNDE, 2006, 154 (12) : 1212 - +
  • [40] Imaging of Chronic Inflammatory Bowel Disease with 18F-FDG PET in Children and Adolescents
    Berthold, L. D.
    Steiner, D.
    Scholz, D.
    Alzen, G.
    Zimmer, K. -P.
    KLINISCHE PADIATRIE, 2013, 225 (04): : 212 - 217